The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2024
Filed:
Jan. 30, 2020
Applicant:
Agency for Science, Technology and Research, Singapore, SG;
Inventors:
Wenn-Chyau Lee, Singapore, SG;
Laurent Renia, Singapore, SG;
Assignee:
Agency for Science, Technology and Research, Singapore, SG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61K 31/137 (2006.01); A61K 31/155 (2006.01); A61K 31/357 (2006.01); A61K 31/366 (2006.01); A61K 31/4706 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 31/635 (2006.01); A61K 31/65 (2006.01); A61K 38/18 (2006.01); A61P 33/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/36 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/357 (2013.01); A61K 31/366 (2013.01); A61K 31/4706 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 31/635 (2013.01); A61K 31/65 (2013.01); A61K 38/18 (2013.01); A61P 33/06 (2018.01);
Abstract
The invention relates to a composition comprising insulin growth factor binding protein 7 (IGFBP7) for treating malaria or reducing the phenomenon of IRB C-endothelial cytoadherence. The composition can further comprise Von Willebrand Factor (VWF) and/or thrombospondin-1 (TSP-1). The composition can also be used as an adjunct therapeutic agent alongside other anti-malarial drugs.